败血症中的肝素:当前的临床发现和可能的机制
Sihan Yu1, Yawen Chi1, Xiaochun Ma1
1Department of Critical Care Medicine, The First Affiliated Hospital of China Medical University, Shenyang, Liaoning, China.
Frontiers in immunology
|December 23, 2024
概括
抗凝药疗法,特别是肝素,对严重凝血激活的败血症患者有希望. 需要进一步的研究来确定生物标志物并优化这种复杂疾病的治疗策略.
科学领域:
- 生物医学研究的研究.
- 临床药理学 临床药理学
- 关键护理医学 关键护理医学
背景情况:
- 败血症涉及凝血,炎症和免疫之间的复杂相互作用.
- 凝血激活是败血症进展到多器官功能障碍的关键因素.
- 目前正在探索抗凝药疗法,特别是肝素,以治疗败血症.
研究的目的:
- 审查抗凝剂治疗在败血症中的潜在益处.
- 使用AI洞察力,识别针对抗凝剂治疗的目标患者群体.
- 讨论肝素在败血症中的机制和临床效用.
主要方法:
- 对早期小型随机对照试验 (RCT) 数据的分析.
- 大型RCT的子组分析和元分析.
- 审查关于肝素在败血症中的生物活动和机制的现有文献.
主要成果:
- 集体证据表明,肝素可能对败血症患者有效,特别是那些严重凝血激活患者.
- 人工智能驱动的研究强调严重的凝血激活是针对性治疗的关键表型.
- 关于最佳抗凝剂的选择,时间和剂量,目前仍在进行争论.
结论:
- 抗凝固药物治疗,特别是肝素,对败血症管理具有前景.
- 进一步的研究,包括大型RCT,对于定义生物标志物和验证临床实用性至关重要.
- 了解肝素在败血症中的精确机制需要进一步的研究.
相关概念视频
Anticoagulant Drugs: Low-Molecular-Weight Heparins
608
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
608
Extrinsic and Intrinsic Pathways of Hemostasis
5.3K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
5.3K
Introduction to Hemostasis
5.5K
Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
5.5K
Clot Retraction and Fibrinolysis
3.8K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
3.8K
Formation of the Platelet Plug
4.2K
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
4.2K
Coagulation
4.6K
The coagulation phase is a critical part of the body's process to prevent blood loss following injury to blood vessels. It involves chemical reactions that form a clot to seal the injured area. The clotting process begins shortly after injury, within 15-20 seconds for severe damage and 1-2 minutes for minor injuries.
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
4.6K


